Your privacy, your choice

We use essential cookies to make sure the site can function. We also use optional cookies for advertising, personalisation of content, usage analysis, and social media.

By accepting optional cookies, you consent to the processing of your personal data - including transfers to third parties. Some third parties are outside of the European Economic Area, with varying standards of data protection.

See our privacy policy for more information on the use of your personal data.

for further information and to change your choices.
Skip to main content
Fig. 5 | BMC Cancer

Fig. 5

From: ADORA2B promotes proliferation and migration in head and neck squamous cell carcinoma and is associated with immune infiltration

Fig. 5

ADORA2B-based nomogram and prognostic evaluation in HNSC. Nomogram integrating ADORA2B expression and clinicopathological factors for predicting 1-, 3-, and 5-year OS in HNSC patients (a). Calibration curves showing the agreement between nomogram-predicted and actual survival probabilities at 1, 3, and 5 years (b). Time-dependent C-index comparison between the nomogram and ADORA2B expression alone (c). Kaplan-Meier survival analysis of HNSC patients stratified by nomogram scores (d). ROC curves for the nomogram predicting 1-, 3-, and 5-year OS (e). Abbreviations: HNSC, head and neck squamous cell carcinoma; OS, overall survival; Concordance index, C-index; ROC, receiver operating characteristic

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us